FDA authorizes emergency use of Remdesivir to treat COVID-19 patients
- 4 years ago
미 식품의약국, 코로나19 치료제로 렘데시비르 긴급사용 승인
The U.S. Food and Drug Administration has given a green light to the most promising treatment so far to tackle COVID-19.
The FDA authorized the emergency use of experimental antiviral drug Remdesivir on Friday.
The drug maker Gilead Sciences said that it's donating 1-point-5 million vials of the drug and will work with the federal government to help patients in need.
The news comes days after preliminary results from a study showed that the drug could help patients recover faster.
The American drug company had originally developed Remdesivir to treat Ebola.
The U.S. Food and Drug Administration has given a green light to the most promising treatment so far to tackle COVID-19.
The FDA authorized the emergency use of experimental antiviral drug Remdesivir on Friday.
The drug maker Gilead Sciences said that it's donating 1-point-5 million vials of the drug and will work with the federal government to help patients in need.
The news comes days after preliminary results from a study showed that the drug could help patients recover faster.
The American drug company had originally developed Remdesivir to treat Ebola.